{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:39:49Z","timestamp":1789767589144,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Operational Program for Competitiveness and Internationalization"},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Norte 2020-Programa Operacional Regional do Norte"},{"name":"European Regional Development"},{"name":"Operational Programme for Competitiveness and Internationalization COMPETE 2020"},{"name":"Portuguese national funds"},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Portuguese Society of Dermatology and Venereology"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jaad.2018.08.032","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T02:55:21Z","timestamp":1535424921000},"page":"660-669.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma"],"prefix":"10.1016","volume":"80","author":[{"given":"Manuel Ant\u00f3nio","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Pestana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Pardal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Vinagre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostinho","family":"Sanches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.08.032_bib1","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaad.2018.08.032_bib2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejca.2015.06.110","article-title":"Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline","volume":"51","author":"Stratigos","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2018.08.032_bib3","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2018.08.032_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","article-title":"Cutaneous squamous-cell carcinoma","volume":"344","author":"Alam","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.08.032_bib5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.08.032_bib6","first-page":"135","article-title":"Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma","volume":"29","author":"Reschly","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2018.08.032_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk Factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.08.032_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3181\/00379727-214-44075","article-title":"Replicative senescence and cell immortality: the role of telomeres and telomerase","volume":"214","author":"Chiu","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.jaad.2018.08.032_bib9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jaad.2018.08.032_bib10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jaad.2018.08.032_bib11","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaad.2018.08.032_bib12","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2018.08.032_bib13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/modpathol.2013.167","article-title":"Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma","volume":"27","author":"Scott","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2018.08.032_bib14","doi-asserted-by":"crossref","first-page":"e80354","DOI":"10.1371\/journal.pone.0080354","article-title":"TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma","volume":"8","author":"Griewank","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2018.08.032_bib15","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/jid.2014.163","article-title":"TERT promoter mutations in skin cancer: the effects of sun exposure and x-irradiation","volume":"134","author":"Populo","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2018.08.032_bib16","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1073\/pnas.1310522110","article-title":"TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism","volume":"110","author":"Rachakonda","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2018.08.032_bib17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-013-1198-2","article-title":"TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma","volume":"126","author":"Remke","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jaad.2018.08.032_bib18","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2013-3734","article-title":"TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas","volume":"99","author":"Melo","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2018.08.032_bib19","series-title":"AJCC Cancer Staging Manual","year":"2010"},{"key":"10.1016\/j.jaad.2018.08.032_bib20","first-page":"32","article-title":"International statistical classification of diseases and related health problems. Tenth revision","volume":"41","author":"Bramer","year":"1988","journal-title":"World Health Stat Q"},{"key":"10.1016\/j.jaad.2018.08.032_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2018.08.032_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.08.032_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju246","article-title":"TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma","volume":"106","author":"Griewank","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2018.08.032_bib24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bjophthalmol-2015-307503","article-title":"TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis","volume":"100","author":"Lin","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2018.08.032_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anndiagpath.2015.03.005","article-title":"Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites","volume":"19","author":"Cheng","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.jaad.2018.08.032_bib26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1200\/JCO.2005.02.155","article-title":"Mortality risk from squamous cell skin cancer","volume":"23","author":"Clayman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2018.08.032_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaad.2005.02.059","article-title":"Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years","volume":"53","author":"Leibovitch","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.08.032_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/(SICI)1096-9098(199602)61:2<124::AID-JSO6>3.0.CO;2-E","article-title":"Risk factors related to locoregional recurrence in squamous cell carcinoma of the skin","volume":"61","author":"Eroglu","year":"1996","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jaad.2018.08.032_bib29","first-page":"806","article-title":"Squamous cell carcinoma: clinical and pathological features and associated risk factors in an observational study of 118 patients","volume":"106","author":"Diaz-Corpas","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2018.08.032_bib30","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.ejca.2010.02.046","article-title":"Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival","volume":"46","author":"Kyrgidis","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2018.08.032_bib31","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.4161\/onci.22009","article-title":"Trial watch: prognostic and predictive value of the immune infiltrate in cancer","volume":"1","author":"Senovilla","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jaad.2018.08.032_bib32","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","article-title":"Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma","volume":"30","author":"Azimi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2018.08.032_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00737084","article-title":"Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis","volume":"406","author":"Sondergaard","year":"1985","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.jaad.2018.08.032_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.jaad.2018.08.032_bibE1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jaad.2010.08.033","article-title":"A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics","volume":"64","author":"Farasat","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.08.032_bibE2","series-title":"AJCC Cancer Staging Manual","year":"2010"},{"key":"10.1016\/j.jaad.2018.08.032_bibE3","first-page":"32","article-title":"International statistical classification of diseases and related health problems. Tenth revision","volume":"41","author":"Bramer","year":"1988","journal-title":"World Health Stat Q"},{"key":"10.1016\/j.jaad.2018.08.032_bibE4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2018.08.032_bibE5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.08.032_bibE6","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaad.2018.08.032_bibE7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jaad.2018.08.032_bibE8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218324861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218324861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:49:28Z","timestamp":1759272568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218324861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0190962218324861"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.08.032","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}